Short interest in Phathom Pharmaceuticals Inc (NASDAQ:PHAT) decreased during the last reporting period, falling from 17.56M to 17.45M. This put 36.02% of the company's publicly available shares short.

Short interest for Phathom Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Phathom Pharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 958.50K shares traded per day, it would take 18.21 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.